A Clinical Trial on the Antipsychotic Properties of Cannabidiol

Clinical trial NCT00309413 · COMPLETED

Trial details

NCT number: NCT00309413
Sponsor: University of Cologne
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders

Start date: 2006-03-01
Primary completion: 2008-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.